Page 5 - Flipbook
P. 5
Brian Rini, MD: Conflict of Interest
● Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Seattle
Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics,
Merck, Surface Oncology, Aravive, Exelixis, Jannsen, Pionyr
● Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Merck, Corvus, Surface Oncology,
Aravive, Alkermes, Arrowhead, Shionogi, Eisai, Nikang Therapeutics, EUSA, Athenex,
Allogene Therapeutics, Debiopharm
● Stock: PTC therapeutics